These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8582019)

  • 1. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T; Ikeda H; Meguro K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2168-72. PubMed ID: 8582019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
    J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
    Kiyota Y; Kondo T; Maeshiba Y; Hashimoto A; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):22-8. PubMed ID: 9037439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
    J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).
    Sohda T; Meguro K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
    Madhavan GR; Chakrabarti R; Vikramadithyan RK; Mamidi RN; Balraju V; Rajesh BM; Misra P; Kumar SK; Lohray BB; Lohray VB; Rajagopalan R
    Bioorg Med Chem; 2002 Aug; 10(8):2671-80. PubMed ID: 12057656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.
    Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P; Pettersson I; Jeppesen L; Bury PS; Mogensen JP; Wassermann K; Brand CL; Sturis J; Wöldike HF; Fleckner J; Andersen AS; Mortensen SB; Svensson LA; Rasmussen HB; Lehmann SV; Polivka Z; Sindelar K; Panajotova V; Ynddal L; Wulff EM
    J Med Chem; 2002 Feb; 45(4):789-804. PubMed ID: 11831892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on hindered phenols and analogues. V. Synthesis, identification, and antidiabetic activity of the glucuronide of CS-045.
    Yoshioka T; Aizawa Y; Fujita T; Nakamura K; Sasahara K; Kuwano H; Kinoshita T; Horikoshi H
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2124-5. PubMed ID: 1797433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
    Shibata T; Matsui K; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 May; 373(1):85-91. PubMed ID: 10408254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y; Shimura Y; Ikeda H
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
    J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
    Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
    J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
    Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
    Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.